Showing results (91-100 of 226) with videos related to

Sort By:
Pageof 23
Shock (Augusta, Ga.)|July 22, 2015
CT-proAVP IS NOT A GOOD PREDICTOR OF VASOPRESSOR NEED IN SEPTIC SHOCKSaid Laribi, Daphné Lienart, Diego Castanares-Zapatero, et al.
Shock (Augusta, Ga.)|June 25, 2011
Influence of severity of illness on the effects of eritoran tetrasodium (E5564) and on other therapies for severe sepsisAndre C Kalil, Steven P LaRosa, Jagadish Gogate, et al.
Antimicrobial Agents and Chemotherapy|July 22, 2020
Safety and Pharmacokinetics of Recombinant Human Plasma Gelsolin in Patients Hospitalized for Nonsevere Community-Acquired PneumoniaAbla Tannous, Susan L Levinson, James Bolognese, et al.
Case Reports in Nephrology|April 18, 2015
Severe rhabdomyolysis associated with simvastatin and role of ciprofloxacin and amlodipine coadministrationNicolas De Schryver, Xavier Wittebole, Peter Van den Bergh, et al.
Respiratory Care|March 3, 2021
Prone Positioning in Spontaneously Breathing Subjects With Moderate or Severe ARDS During Invasive VentilationAdil Wiart, Diego Castanares-Zapatero, Xavier Wittebole, et al.
Acta Haematologica|September 27, 2020
Management of COVID-19 Coagulopathy in a Patient with Severe Haemophilia AJoão Pinto Pereira, Philippe Hantson, Ludovic Gerard, et al.
Critical Care Medicine|April 11, 2014
The next generation of sepsis clinical trial designs: what is next after the demise of recombinant human activated protein C?*Steven M Opal, R Phillip Dellinger, Jean-Louis Vincent, et al.
The Journal of Molecular Diagnostics : JMD|March 28, 2012
Ligation with nucleic acid sequence-based amplificationCarmichael Ong, Warren Tai, Aartik Sarma, et al.
Pageof 23